Intelligent Living Application Group Inc. (the "Company" or "Intelligent Living"), a premium lockset manufacturer and distributor headquartered in Hong Kong, today announced its unaudited financial ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with ...

Mettler-Toledo International Inc. today announced it will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Tuesday, January 14, 2025 at 3:45 p.m. Pacific Time. A ...

Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor ...

GILD has put up a steady performance in 2024, with a new drug approval, positive data readouts and strong quarterly results.

The Advanced Research Projects Agency for Health (ARPA-H) awarded TigaTx up to $33.5 million in funding. Tessera Therapeutics ...

The program, aimed at reducing how much Americans spend on prescription drugs, includes several precision medicines.

The cyberattack happened earlier this year, the company disclosed. Other industry news comes from CVS, Gilead, Ionis, and more.

Indian equity markets faced a sharp decline as the Nifty 1181 points or 4.77% over the week. This downturn was exacerbated by triggered by the Federal Reserve's hawkish outlook for 2025.

The global cardiometabolic drugs market is projected to grow from US$ 50 billion in 2021 to over US$ 70 billion by 2032, with a CAGR of 4% to 5%. Sales are expected to surpass US$ 55 billion by 2022, ...

Indian equity markets faced a sharp decline as the Nifty 1181 points or 4.77% over the week. This downturn was exacerbated by triggered by the Federal Reserve's hawkish outlook for 2025.

US biotech Assembly Biosciences has announced an equity investment of $20.1 million by Gilead Sciences to purchase additional ...